Pityriasis Rubra Pilaris
Authors:
P. Velčevský 1; O. Kodet 1,2; J. Štork 1
Authors place of work:
Dermatovenerologická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. Jiří Štork, CSc.
1; Anatomický ústav 1. LF UK, Praha, přednosta prof. MUDr. Miloš Grim, DrSc.
2
Published in the journal:
Čes-slov Derm, 86, 2011, No. 3, p. 129-136
Category:
Reviews (Continuing Medical Education)
Summary
Pityriasis rubra pilaris (PRP) is the relatively rare inflammatory skin disease of unknown etiology. As possible trigger factors are considered infections, malignances or autoimmune disturbances, which were observed to precede occurrence of the disease. According to age, morphological features and clinical course the disease is classified into six forms. The most common is classic adult form, representing over 50 % of PRP cases, which is also characterized by high spontaneous remission. Typical skin lesion include erythematosquamous salmon-colored plaques and areas often evolving in erytroderma with well demarcated islands of normal skin, follicular papules, palmoplantar keratoderma. Histology shows hyperkeratosis with alternating orthokeratosis and parakeratosis in a chessboard pattern, and focal acantholytic dyskeratosis. Mainstay of the treatment is systemic therapy with retinoids, methotrexate and cyclosporine. Good effect of “biologics“ used in psoriasis was observed also in the therapy of PRP.
Key words:
pityriasis rubra pilaris – pathogenesis – classification – therapy
Zdroje
1. ABBOTT, R. A., GRIFFITHS, W. A. Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years. Clin. Exp. Dermatol., 2009, 34, 3, p. 378–379.
2. AL-NATOUR. Pityriasis rubra pilaris: Report of 16 cases in Saudi Arabia. J. Am. Acad. Dermatol., 2010, P3330, p. AB130.
3. ALBERT, M. R., MACKOOL, B. I. Pityriasis rubra pilaris. Int. J. Dermatol., 1999, 38, 1, p. 1–11.
4. ALLISON, D. S., EL-AZHARY, R. A., CALOBRISI, S. D. et al. Pityriasis rubra pilaris in children. J. Am. Acad. Dermatol., 2002, 47, 3, p. 386–389.
5. AUFFRET, N., QUINT, L., DOMART, P. et al. Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J. Am. Acad. Dermatol., 1992, 27, p. 260–261.
6. BERRY, M., KHACHEMOUNE, A. Extensive tinea versicolor mimicking Pityriasis rubra pilaris. J. Drugs Dermatol., 2009, 8, 5, p. 490–491.
7. BESNIER, E. Observation pour server a historic clinique du pityriasis rubra pilaris (In French). Am. Dermatol. Syphil. (Paris), 1889, 10, p. 253–287.
8. BETTO, P., VASSILOPOULOU, A., COLOMBARI, R., VELLER-FORNASA, C. Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection. G. Ital. Dermatol. Venereol., 2008, 143, 4, p. 271–273.
9. BLAUVELT, A., NAHASS, G. T., PARDO, R. J. et al. Pityriasis rubra pilaris and HIV infection. J. Am. Acad. Dermatol., 1991, 24, p. 703–705.
10. BOROK, M., LOWE, N. J. Pityriasis rubra pilaris. J. Am. Acad. Dermatol., 1990, 22, p. 792–795.
11. BRAUN-FALCO, O., RYCKMANNS, F., SCHMOECKEL, C. et al. Pityriasis Rubra Pilaris: A Clinico-Pathological and Therapeutic Study with Speciál Reference to Histochemistry, Autoradiography, and Electron Microscopy. Arch. Dermatol. Res., 1983, 275, p. 287–295.
12. CLAYTON, BD., JORIZZO, JL., HITCHCOCK, MG., et al. Adult pityriasis rubra pilaris: a 10-year case series. J. Am. Acad. Dermatol., 1997, 36, p. 959–964.
13. CORAS, B., VOGT, T. H., ULRICH, H. et al. Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? Br. J. Dermatol., 2005, 152, p. 388–389.
14. COWEN, P., O’KEEFE, R. Pityriasis rubra pilaris and focal acantholytic dyskeratosis. Australas J. Dermatol., 1997, 38, p. 40–41.
15. COX, V., LESESKY, E. B., GARCIA, B. D. et al. Treatment of juvenile pityriasis rubra pilaris with etanercept. J. Am. Acad. Dermatol., 2008, 59, 5, p. 113–114.
16. DAVIS, K. F., WU., J. J., MURASE, J. E. et al. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch. Dermatol., 2007, 143, 12, p. 1597–1599.
17. DE BEURMANN, B. H. Pityriasis rubra pilaire familial. Ann. Dermatol. Syphiligr. (Paris) 1910, 1, 5, p. 609–619.
18. DICKEN, CH. Treatment of classic pityriasis rubra pilaris. J. Am. Acad. Dermatol., 1994, 31, p. 997–999.
19. DOOREN-GREEBE, R. J., KERKHOF, P. C. Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. J. Am. Acad. Dermatol., 1995, 32, p. 322–325.
20. DOUGHTY, L. E., WELLS, M. J., STETSON, C. L. Pityriasis rubra pilaris with epidermolytic hyperkeratosis. J. Drugs Dermatol., 2008, 7, 10, p. 978–979.
21. EVANGELOU, G., MURDOCH, S. R., PALAMARAS, I. et al. Photoaggravated pityriasis rubra pilaris. Photodermatol. Photoimmunol. Photomed., 2005, 21, 5, p. 272–274.
22. GARCOVICH, S., DI GIAMPETRUZZI, A. R., ANTONELLI, G. et al. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series. JEADV, 2010, 24, p. 881–884.
23. GOLDSMITH, L. A., WEINRICH, A. E., SHUPACK, J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J. Am. Acad. Dermatol., 1982, 6, p. 710–715.
24. GÓMEZ-MOYANO, E., CRESPO-ERCHIGA, A., VERA CASA—O, A. et al. Pitiriasis rubra pilaris acantolítica durante tratamiento con imiquimod 5% Rema. Actas Dermosifiliogr, 2010, 101(10), p. 898-900.
25. GONZALEZ-LOPEZ, A., VELASCO, E., POZO, T. et al. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br. J. Dermatol., 1999, 140, p. 931–934.
26. GREGORIOU, S., ARGYRIOU, G., CHRISTOFIDOU, E. et al. Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%. J. Drugs Dermatol., 2007, 6, 3, p. 340–342.
27. GRIFFITHS, W. A. Pityriasis rubra pilaris. Clin. Exp. Dermatol., 1980, 5, p. 105.
28. GRIFFITHS, W. A. Vitamin A and pityriasis rubra pilaris. J. Am. Acad. Dermatol., 1982, 7, p. 555.
29. GUEDES, R., LEITE, L. Treatment of pityriasis rubra pilaris with etanercept. Dermatol. Ther., 2011, 24, 2, p. 285–286.
30. HAENSSLE, H. A., BERTSCH, H. P., EMMERT, S. et al. Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris. Clin. Exp. Dermatol., 2004, 29, 3, p. 244–246.
31. HERBST, R. A., VOGELBRUCH, M., EHNIS, A. et al. Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris. Br. J. Dermatol., 2000, 142, p. 574–575.
32. HIRAO, A., KAWADA, A., OISO, N. et al. Pityriasis rubra pilaris with preceding cytomegalovirus infection. J. Am. Acad. Dermatol., 2010, P3324, p. AB129.
33. HOFER, A., MÜLLEGGER, R., KERL, H. et al. Extracorporeal photochemotherapy for the treatment of erythrodermic pityriasis rubra pilaris. Arch. Dermatol., 1999, 135, p. 475–476.
34. HUNTER, G. A., FORBES, I. J. Treatment of pityriasis rubra pilaris with azathioprine. Br. J. Dermato., 1972, 87, 1, p. 42–45.
35. CHAN, H., LIU, F. T., NAGUWA, S. A Review of Pityriasis Rubra Pilaris and Rheumatologic Associations. Clinical & Developmental Immunology, 2004, 11, 1, p. 57–60.
36. IREDALE, H. E., MEGGITT, S. J. Photosensitive pityriasis rubra pilaris. Clin. Exp. Dermatol., 2006, 31, 1, p. 36–38.
37. KARIMIAN-TEHERANI, D., PARISSA, M., TANEW, A. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. Pediatr. Dermatol., 2008, 25, 1, p. 125–126.
38. KASKEL, P., KOLLMAN-GRUNDMANN, M., SCHILLER, M. I. et al. Bath-PUVA as treatment for pityriasis rubra pilaris provoked by ultraviolet B. Br. J. Dermatol., 1999, 140, p. 769–770.
39. KAWARA, S., MIYAKE, M., OISO, N. et al. Pityriasis rubra pilaris with preceding cytomegalovirus infection. Dermatology, 2009, 219, 4, p. 350–352.
40. KEER, A. C., FERGUSON, J. Type II adult-onset pityriasis rubra pilaris successfully treated with intravenous immunoglobulin. Br. J. Dermatol., 2007, 156, p. 1055–1056.
41. KLEIN, A., SZEIMIES, R. M., LANDTHALER, M. et al. Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology, 2007, 215, 1, p. 72–75.
42. KNUDSEN, E. A. Pityriasis rubra pilaris in identical twins. Br. J. Dermatol., 1958, 70, p. 27–29.
43. KOLEY, S., CHOUDHARY, S., SALODKAR, A. et al. Circumscribed juvenile type pityriasis rubra pilaris (type 4): are we missing them. Journal of Pakistan Association of Dermatologists, 2010, 20, p. 98–102.
44. LIN, W. L., LIN, W. C., SHIH, I. H. et al. Juvenile pityriasis rubra pilaris in Chang Gung Memorial Hospital. Taipei and Linkou: a retrospective study in the past ten years. Dermatol. Sinica, 2007, 25, p. 248–55.
45. LOWENTHAL, K. E., HORN, P. J., KALB, R. E. Concurrent use of methotrexate and acitretin revisited. J. Dermatolog. Treat., 2008, 19, 1, p. 22–26.
46. MAGRO, C. M., CROWSON, A. N. The clinical and histomorphological features of pityriasis rubra pilaris – a comparative analysis with psoriasis. J. Cutan. Pathol., 1997, 24, p. 416–24.
47. MARTINEZ CALIXTO, L. E., SURESH, L., MATSUMURA, E. et al. Oral pityriasis rubra pilaris. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101, 5, p. 604–607.
48. MIRALLES, E. S., NUNEZ, M., DE LAS HERAS, M. E. et al. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br. J. Dermatol., 1995, 133, p. 990–993.
49. MOLIN, S., RUZICKA, T. Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br. J. Dermatol., 2010, 163, 1, p. 221–223.
50. MUHTEREM, P. et al. Dermatomyositis with a Pityriasis Rubra Pilaris-like Eruption: An Uncommon Cutaneous Manifestation in Dermatomyositis. Pediatr. Dermatol., 2007, 24, 2, p. 151–154.
51. MÜLLER, H., GATTRINGER, C., ZELGER, B. et al. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J. Am. Acad. Dermatol., 2008, 59, 5, Suppl, p. 65–70.
52. NEESS, C. M., HINRICHS, R., DISSEMOND, J. Treatment of pruritus by capsaicin in a patient with pityriasis rubra pilaris receiving RE-PUVA therapy. Clin. Exp. Dermatol., 2000, 25, 3, p. 209–211.
53. NIEMI, K. M., KOUSA, M., STORGARDS, K. et al. Pityriasis rubra pilaris. A clinico-pathological study with a special reference to autoradiography and histocompatibility antigens. Dermatologica, 1976, 152, 2, p. 109–118.
54. O’KANE, D., DEVEREUX, C. E., WALSH, M. Y. et al. Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment. Clin. Exp. Dermatol., 2010, 35, 4, p. e155–e156.
55. RASI, A., SOLTANI-ARABSHAHI, R., NARAGHI, Z. S. Circumscribed juvenile-onset pityriasis rubra pilaris with hypoparathyroidism and brachyonychia. Cutis, 2006, 77, 4, p. 218–222.
56. REINHARDT, L. A., ROSEN, T. Pityriasis rubra pilaris as the initial manifestation of leukemia. Cutis, 1983, 31, p. 100–102.
57. RUIZ, V. R., SÁNCHEZ, C. D. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy. Eur. J. Dermatol., 2010, 20, p. 630–631.
58. SANCHEZ-REGANA, M., CREUS, L., UMBERT, P. Pityriasis rubra pilaris. A long-term study of 25 cases. Eur. J. Dermatol., 1994, 4, p. 593–597.
59. SANCHEZ-REGANA, M., FUENTES, C. G., CREUS, L. et al. Pityriasis rubra pilaris and HIV infection: a part of the spectrum of HIV-associated follicular syndrome. Br. J. Dermatol., 1995, 133, p. 818–819.
60. SANCHEZ-REGANA, M., LOPEZ-GIL, F., SALLERAS, M. et al. Pityriasis rubra pilaris as the initial manifestation of internal neoplasia. Clin. Exp. Dermatol., 1995, 20, p. 436–438.
61. SEBASTIAN, A., KOFF, A. B., GOLDBERG, L. J. PRP with subcorneal acantholysis: Case report and review. J. Cutan Pathol., 2010, 37, p. 99–101.
62. SECKIN, D., TULA, E., ERGUN, T. Successful use of etanercept in type I pityriasis rubra pilaris. Br. J. Dermatol., 2008, 158, 3, p. 642–644.
63. SEHGAL, V. N., JAIN, M. K., MATHUR, R. P. Pityriasis rubra pilaris in Indians. Br. J. Dermatol., 1989, 121, p. 821–822.
64. SEHGAL, V. N., SRIVASTAVA, G. (Juvenile) Pityriasis rubra pilaris. Int. J. Dermatol., 2006, 45, p. 438–446.
65. SHARMA, S., WEISS, G. R., PAULGER, B. Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma. Dermatology, 1997, 194, 2, p. 166–167.
66. SCHREML, S., ZELLER, V., BABILAS, P. et al. Pityriasis rubra pilaris successfully treated with adalimumab. Clin. Exp. Dermatol., 2010, 35, 7, p. 792–793.
67. SCOTT, J., LEE, T. M. Differential Diagnosis for the Dermatologist. Berlin Heidelberg: Springer-Verlag, 2008, p. 1008–1010,
68. SONNEX, T. S., DAWBER, R. P., ZACHARY, C. B. et al. The nails in adult type 1 pityriasis rubra pilaris. A comparison with Sézary syndrome and psoriasis. J. Am. Acad. Dermatol., 1986, 15, p. 956–960.
69. STOLL, D. M., KING, L. E., CHYTIL, F. Serum levels of retinol binding protein in patients with pityriasis rubra pilaris. Br. J. Dermatol., 1983, 108, p. 375.
70. TARRAL C. General psoriasis. Desquamation from the parts covered with hair. In Rayer P. A Theoretical and Practical Treatise on the Diseases of the Skin. 2nd ed. London: Baillière, 1835, p. 648–649.
71. USUKI, K., SEKIYAMA, M., SHIMADA, T. et al. Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A. Dermatology, 2000, 200, 4, p. 324–327.
72. VAHLQUIST, A. Retinol binding protein and pityriasis rubra pilaris. Br. J. Dermatol., 1982, 107, p. 125–127.
73. VANDERHOOFT, S. L., FRANCIS, J. S., HOLBROOK, K. A. et al. Familial pityriasis rubra pilaris. Arch. Dermatol., 1995, 131, 4, p. 448–453.
74. VASHER, M., SMITHBERGER, E., LIEN, M. H. et al. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept. J. Drugs Dermatol., 2010, 9, 7, p. 844–850.
75. VERGILIS-KALNER, I. J., MANN, D. J., WASSERMAN, J. et al. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy. J. Drugs Dermatol., 2009, 8, 3, p. 270–273.
76. VURAIRAJ, V. D., HORSLEY, M. B. Resolution of Pityriasis Rubra Pilaris-Induced Cicatricial Ectropion With Systemic Low-Dose Methotrexate. Am. J. Ophthal., 2007, 143, p. 709–710.
77. WALLING, H. W., SWICK, B. L. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch. Dermatol., 2009, 145, p. 99–101.
78. WETZIG, T., STICHERING, M. Juvenilie pityriasis rubra pilaris: successful treatment with ciclosporin. Br. J. Dermatol., 2003, 149, p. 202–203.
79. WOHLRAB, J., KREFT, B. Treatment of Pityriasis Rubra Pilaris with Ustekinumab. Br. J. Dermatol., 2010, 163, p. 655–656.
80. YANG, F. C., JESSUP, C., DAHIYA, M. et al. Pityriasis rubra pilaris exacerbation with topical use of imiquimod. Int. J. Dermatol., 2008, 47, p. 1076–1078.
81. YANIV, R., BARZILAI, A., TRAU, H. Pityriasis rubra pilaris Exacerbated by Ultraviolet B Phototherapy. Dermatology, 1994, 189, p. 313.
Štítky
Dermatology & STDs Paediatric dermatology & STDsČlánok vyšiel v časopise
Czech-Slovak Dermatology
2011 Číslo 3
Najčítanejšie v tomto čísle
- Pityriasis Rubra Pilaris
- Miliaria Pustulosa
- The Significance of Diagnostic Hypoallergenic Diet in Patients with Atopic Eczema
- Follow-up of Patients with Melanoma